Binaural Sound for Remimazolam Induction

Yonsei University Health System (YUHS)

Status: Enrolling

Conditions: Uterine Myoma; General Anesthesia; Prostate Cancer

Treatments: Procedure: Binaural sound; Procedure: Placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT06099977

3-2023-0305

Details and patient eligibility

About

It is important to decrease the time-to-loss of consciousness and anesthetics dose of remimazolam for general anesthesia induction. We will evaluate the effect of binaural sound for general anestheia induction using remimazolam infusion.

Enrollment: 72 estimated patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients scheduled for generla anesthesia
2. Patients aged 20-60
3. Patients with American Society of Anesthesiologist physical status classification 1-2
4. Patients with ideal body weight 50-80 kg

Exclusion criteria

1. Patients with hearing disability
2. Patients using opioids or sedatives in 1 week
3. Patients who are dependent for alcoholics or drugs
4. Patients with hypersensitivities to remimazolam
5. Patients with arrhythmia, cardiovascular disease, heart failure, or hypovolemia
6. Patients with liver failure

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

72 participants in 2 patient groups, including a placebo group

I (Binaural)

Experimental group

Description:

Binaural sound using headphone will be applied.

Treatment:

Procedure: Binaural sound

II (Placebo)

Placebo Comparator group

Description:

Only headphone without sound will be applied.

Treatment:

Procedure: Placebo